SecBot SecBot

CRLBF

Cresco Labs Inc.
OTC· Medicinal Chemicals & Botanical Products· Inc. A1· CIK 0001832928 Biotech & Drug Discovery
$0.6130 −0.00 (−0.65%)
Oct 27 4:00 PM ET · prev $0.6170
Median target
$2.00
+226% · range $2.00–2.00
1 year
−48.9%
from $1.20 · Oct 28
30 days
−19.3%
from $0.7600
52-week range
$0.5760–1.92
−68% from high · low Oct 19
Avg volume 20D
672.3K
Sep 30 spike 3.07M
Short interest
1.39M
+29.6%
Days to cover
1.3
at average volume
Filing reports
4
analyzed by SecBot
SecBot read MIXED 3 reports · 90 days
Balance 0 bearish · 0 bullish · 1 mixed · 2 neutral oldest → newest, height = score
Avg score ·High conf. 3/3
Strongest NEUTRAL Cresco Labs filed a management information circular for its October 30, 2026 annual general and special…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • Short sellersBUILDING

    Short interest +29.6% to 1.39M shares. 1.3 days to cover.

  • TrendDOWNTREND

    13% below its 50-day average.

The Street

last action Aug 2024
12-month targets · 1 analysts

Price is below the lowest target. Median implies +226%.Targets as of Oct 28, 2026.

Recent actions
DateFirmActionRating
Aug 12, 2024Needham
REITERATE
REITERATEHold
Jun 12, 2024Zuanic & Associates
INITIATE
INITIATEOverweight
May 16, 2024Wedbush
MAINTAIN
MAINTAINOutperform
May 16, 2024Needham
REITERATE
REITERATEHold
Mar 14, 2024Roth MKM
MAINTAIN
MAINTAINNeutral
Mar 20, 2023Wedbush
MAINTAIN
MAINTAINOutperform

Earnings setup

Estimates
−$0.03
EPS estimate, this quarter
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.03-$0.03–-$0.03No data$173.7M
Next Q-$0.03-$0.03–-$0.03No data$173.9M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
1,388,290
shares short
+29.6%
vs prior settlement
1.3
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Oct 13, 2026 SEC
Cresco Labs filed a supplement to its management information circular clarifying voting rights and minority approval…
6-K · Impact 2/10
Sep 30, 2026 SEC
Cresco Labs filed a management information circular for its October 30, 2026 annual general and special meeting…
6-K · Impact 5/10
Aug 6, 2026 SEC
Cresco Labs reported Q2 2026 revenue of $173.3M (+5.9% YoY) and net income of $15.4M, swinging from a -$13.9M loss in…
6-K · Impact 6/10

SecBot reports

4 filings · 0 bullish · 1 bearish · 1 mixed · 2 neutral
All CRLBF filing & press-release reports (4)